𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Animal models of peripheral neuropathy: The trembler mouse

✍ Scribed by J. G. McLeod; P. A. Low

Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
958 KB
Volume
2
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

One of the features of the IVth International Congress on Neuromuscular Diseases, held in Montreal September 17–21, 1978, was a series of invited posters. In order to achieve a wider audience for this valuable material, we have made arrangements to publish a number of these posters in Muscle & Nerve. This is the third poster in this series. To preserve the original effect of the posters, they are being reproduced almost exactly as they appeared at the Congress, without editing or other alterations. We hope you will find this feature a useful addition to your Journal.

πŸ“œ SIMILAR VOLUMES

Depleting endogenous neurotrophin-3 enha
Depleting endogenous neurotrophin-3 enhances myelin formation in the Trembler-J mouse, a model of a peripheral neuropathy
✍ Ning Liu; Sushama Varma; David Tsao; Eric M. Shooter; Ravi J. Tolwani πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 258 KB

## Abstract The heterozygous Trembler‐J (TrJ/+) mouse, containing a point mutation in the peripheral myelin protein 22 (__Pmp22__) gene, is characterized by severe hypomyelination and is a representative model of Charcot‐Marie‐Tooth 1A (CMT1A) disease/Dejerine‐Sottas syndrome (DSS). Given that the

Animal Models of Chemotherapy-Evoked Pai
Animal Models of Chemotherapy-Evoked Painful Peripheral Neuropathies
✍ Nicolas Authier; David Balayssac; Fabien Marchand; Bing Ling; Aude Zangarelli; J πŸ“‚ Article πŸ“… 2009 πŸ› Springer-Verlag 🌐 English βš– 96 KB

This review examines recent preclinical research on toxic peripheral neuropathy and potential therapeutic developments. Chemotherapy-induced peripheral neurotoxicity is a major clinical problem because it represents the dose-limiting side effects of a significant number of antineoplastic drugs. Pati